ZA979655B - Conjugates useful in the treatment of prostate cancer. - Google Patents

Conjugates useful in the treatment of prostate cancer.

Info

Publication number
ZA979655B
ZA979655B ZA9709655A ZA979655A ZA979655B ZA 979655 B ZA979655 B ZA 979655B ZA 9709655 A ZA9709655 A ZA 9709655A ZA 979655 A ZA979655 A ZA 979655A ZA 979655 B ZA979655 B ZA 979655B
Authority
ZA
South Africa
Prior art keywords
treatment
prostate cancer
conjugates useful
conjugates
useful
Prior art date
Application number
ZA9709655A
Other languages
English (en)
Inventor
Victor M Garsky
Dong-Mei Feng
Deborah Defeo-Jones
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of ZA979655B publication Critical patent/ZA979655B/xx

Links

ZA9709655A 1996-10-30 1997-10-28 Conjugates useful in the treatment of prostate cancer. ZA979655B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2922496P 1996-10-30 1996-10-30

Publications (1)

Publication Number Publication Date
ZA979655B true ZA979655B (en) 1998-04-30

Family

ID=21847913

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9709655A ZA979655B (en) 1996-10-30 1997-10-28 Conjugates useful in the treatment of prostate cancer.

Country Status (2)

Country Link
CN (1) CN1239204C (xx)
ZA (1) ZA979655B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2754846C (en) * 2009-03-09 2015-05-12 Ktb Tumorforschungsgesellschaft Mbh Prostate-specific antigen cleavable prodrugs

Also Published As

Publication number Publication date
CN1239204C (zh) 2006-02-01
CN1242708A (zh) 2000-01-26

Similar Documents

Publication Publication Date Title
EP0926955A4 (en) Conjugates useful in the treatment of prostate cancer
HK1024876A1 (en) Conjugates useful in the treatment of prostate cancer
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
HUP0104857A3 (en) New cancer treatments
IL136167A0 (en) Conjugates useful in the treatment of prostate cancer
EP0855910A4 (en) CONJUGATES USEFUL FOR TREATING BENIN PROSTATIC ADENOMA
ZA9810974B (en) Conjugates useful in the treatment of prostate cancer
EG22346A (en) Process for the preparation of conjugates useful in the treatment of prostate cancer
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
ZA979655B (en) Conjugates useful in the treatment of prostate cancer.
GB9626309D0 (en) Conjugates useful in the treatment of prostate cancer
GB9624170D0 (en) Conjugates useful in the treatment of prostate cancer
SI0942754T1 (en) Conjugates useful in the treatment of prostate cancer
HK1034979A1 (en) Conjugates useful in the treatment of prostate cancer.
GB9718160D0 (en) Conjugates useful in the treatment of prostate cancer
GB9804361D0 (en) Cancer treatment
GB9804399D0 (en) Conjugates useful in the treatment of prostate cancer
GB9815855D0 (en) Conjugates useful in the treatment of prostate cancer
GB9810183D0 (en) Conjugates useful in the treatment of prostate cancer
GB9827102D0 (en) New cancer treatments
GB9903035D0 (en) Treating cancer
EP0871709A4 (en) CELLULAR LINE OF METASTASIS PROSTATE CANCER, IN MAN, HAVING RECOGNIZED UNDER THE INFLUENCE OF AN ANDROGEN
ZA978162B (en) Means for treating prostate hypertrophy and prostate cancer.
GB2334579B (en) Treating cancer
AU4598100A (en) Treating cancer